References
- Abernathy, C.O., et al., 1996. Is ingested inorganic arsenic a “threshold” carcinogen? Fundamental and applied toxicology, 29(2), 168–175.
- Alamolhodaei, N.S., Shirani, K., and Karimi, G., 2015. Arsenic cardiotoxicity: an overview. Environmental toxicology and pharmacology, 40(3), 1005–1014.
- Alessio, L., Campagna, M., and Lucchini, R., 2007. From lead to manganese through mercury: mythology, science, and lessons for prevention. American journal of industrial medicine, 50(11), 779–787.
- Ali, I., 2018. Microwave assisted economic synthesis of multi walled carbon nanotubes for arsenic species removal in water: batch and column operations. Journal of molecular liquids, 271, 677–685.
- Ali, I., et al., 2014. Removal of arsenic species from water by batch and column operations on bagasse fly ash. Environmental science and pollution research, 21(5), 3218–3229.
- Ali, I., Tabrez, A.K., and Asim, M., 2011. Removal of Arsenic from water by electrocoagulation and electrodialysis techniques. Separation & purification reviews, 40(1), 25–42.
- Ali, I., Tabrez, A.K., and Hussain, I., 2011. Treatment and remediation methods for arsenic removal from the ground water. International journal of environmental engineering, 3(1), 48–71.
- Bouatra, S., et al., 2013. The human urine metabolome. PLoS one, 8(9), e73076.
- Campagna, M., et al., 2016. Metabolomic patterns associated to QTc interval in shiftworkers: an explorative analysis. Biomarkers, 21(7), 607–613.
- Cohen, S.M., Chowdhury, A., and Arnold, L.L., 2016. Inorganic arsenic: a non-genotoxic carcinogen. Journal of environmental sciences (sciences), 49, 28–37.
- Dudka, I., et al., 2014. Metabonomic analysis of serum of workers occupationally exposed to arsenic, cadmium and lead for biomarker research: a preliminary study. Environment international, 68, 71–81.
- Dunn, W.B., et al., 2011. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chemical society reviews, 40(1), 387–426.
- Eriksson, L., et al., 2013. Orthogonal PLS (OPLS). In: Multi- and megavariate data analysis: basic principles and applications. 3rd ed. Malmö: MKS Umetrics AB, 89–115.
- García-Sevillano, M.A., et al., 2014a. Metabolomic study in plasma, liver and kidney of mice exposed to inorganic arsenic based on mass spectrometry. Analytical and bioanalytical chemistry, 406(5), 1455–1469.
- García-Sevillano, M.Á., et al., 2014b. A combination of metallomics and metabolomics studies to evaluate the effects of metal interactions in mammals: application to Mus musculus mice under arsenic/cadmium exposure. Journal of proteomics, 2(104), 66–79.
- García-Sevillano, M.Á., García-Barrera, T., and Gómez-Ariza, J.L., 2015. Environmental metabolomics: biological markers for metal toxicity. Electrophoresis, 36(18), 2348–2365.
- Huang, Y., et al., 2013. Discovery of safety biomarkers for realgar in rat urine using UFLC-IT-TOF/MS and 1H NMR based metabolomics. Analytical and bioanalytical chemistry, 405(14), 4811–4822.
- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012. Arsenic, metals, fibres, and dusts. A Review of human carcinogens. Lyon, France: The International Agency for Research on Cancer.
- Kuo, C.C., et al., 2015. Arsenic exposure, arsenic metabolism, and incident diabetes in the strong heart study. Diabetes care, 38(4), 620–627.
- Laine, J.E., et al., 2017. Neonatal metabolomic profiles related to prenatal arsenic exposure. Environmental science & technology, 51(1), 625–633.
- Landrigan, P., 2017. The power of environmental protection: arsenic in drinking water. The lancet public health, 2(11), e488–e489.
- Liu, J., et al., 2002. Chronic arsenic poisoning from burning high-arsenic-containing coal in Guizhou, China. Environmental health perspectives, 110(2), 119–122.
- National Research Council (U.S.), Subcommittee on Arsenic in Drinking Water, 1999. Arsenic in drinking water. National Academy Press. Available from: http://www.who.int/en/news-room/fact-sheets/detail/arsenic [Accessed 28 November 2018].
- Navas-Acien, A., et al., 2008. Arsenic exposure and prevalence of type 2 diabetes in US adults. Jama, 300(7), 814–822.
- Nearing, M.M., Koch, I., and Reimer, K.J., 2014. Complementary arsenic speciation methods: a review. Spectrochimica acta part B: atomic spectroscopy, 99, 150–162.
- Nigra, A.E., et al., 2017. The effect of the Environmental Protection Agency maximum contaminant level on arsenic exposure in the USA from 2003 to 2014: an analysis of the National Health and Nutrition Examination Survey (NHANES). The lancet public health, 2(11), e513–e521.
- Shen, H., et al., 2013. Urinary metabolic biomarkers link oxidative stress indicators associated with general arsenic exposure to male infertility in a Han Chinese Population. Environmental science and technology, 47(15), 8843−8851.
- Società Italiana Valori di Riferimento, 2005. Valori di riferimento degli elementi metallici di interesse biologico e tossicologico. LISTA SIVR. Available from: http://associazione.squarespace.com/valori-riferimento [Accessed 28 November 2018].
- Subramanian, K.S., 1989. Determination of arsenic in urine by graphite platform furnace atomization atomic absorption spectrometry. Science of the total environment, 89(3), 311–315.
- Vermeulen, R., 2017. The use of high-resolution metabolomics in occupational exposure and health research. Annals of work exposures and health, 61(4), 395–397.
- Wang, C., et al., 2014. The metabolomic profiling of serum in rats exposed to arsenic using UPLC/Q-TOF MS. Toxicology letters, 229(3), 474–481.
- Wei, L., et al., 2009. Metabolic profiling studies on the toxicological effects of realgar in rats by 1H NMR spectroscopy. Toxicology and applied pharmacology, 234(3), 314–325.
- Zhang, J., et al., 2014. Urinary metabolomics revealed arsenic internal dose-related metabolic alterations: a proof-of-concept study in a Chinese male cohort. Environmental science & technology, 48(20), 12265–12274.
- Zheng, L.Y., et al., 2015. The association of urine arsenic with prevalent and incident chronic kidney disease: evidence from the Strong Heart Study. Epidemiology, 26(4), 601–612.